(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SECURACELL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SECURACELL

ST13

US500000079247120

Class

1, 5

Filing

79247120

Registration

6020962

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

08/15/2025

Trademark type

Word

Nice classes

1, 5

Filing date

09/05/2018

Registration date

03/31/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/31/2020

Last transaction

08/15/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

AU

Examiner

MASON,JARED MICHAEL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Immulab Pty Ltd

Representatives

Rebecca Liebowitz VENABLE LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical and biological reagents for researchscientific and medical laboratory use; chemical and biological diagnostic reagents for researchscientificclinical and medical laboratory use; cell cultures and media for researchscientificdiagnostic and laboratory use; diagnostic preparations and substances for researchscientificclinicaldiagnostic and medical laboratory use

Class 5

reagent red blood cells for quality control in immunohematology tests for clinical medical use; diagnostic reagent red blood cells for quality control in immunohematology tests for medical purposes; chemical reagents for clinical medical use; chemical diagnostic reagents for medical purposes; cell cultures and reagents for clinical medical use; diagnostic preparations for clinical medical use; reagent red blood cell and diagnostic preparations for clinical medical use

Publications

History of USPTO decisions and trademark events.

35 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/14/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/31/2025

FINP

FINAL DECISION TRANSACTION PROCESSED BY IB

06/07/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/04/2020

GPNX

NOTIFICATION PROCESSED BY IB

11/21/2020

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

11/03/2020

XXCR

GENERIC MADRID TRANSACTION CREATED

11/03/2020

IRRH

IRREGULARITY FROM IB EXAMINED BY MPU

10/19/2020

IRFI

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB

09/14/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/06/2020

FIMP

FINAL DISPOSITION PROCESSED

08/05/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/30/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

03/31/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/14/2020

PUBO

PUBLISHED FOR OPPOSITION

01/14/2020

GPNX

NOTIFICATION PROCESSED BY IB

01/10/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/25/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/25/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/25/2019

ALIE

ASSIGNED TO LIE

12/11/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/18/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/15/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/15/2019

DOCK

ASSIGNED TO EXAMINER

11/05/2019

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

05/22/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/17/2019

CNRT

NON-FINAL ACTION WRITTEN

05/16/2019

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

01/15/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/01/2019

CNRT

NON-FINAL ACTION WRITTEN

12/31/2018

MAFR

APPLICATION FILING RECEIPT MAILED

12/18/2018

DOCK

ASSIGNED TO EXAMINER

12/15/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/13/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/06/2018

Continuous trademark protection

Get notified about every new filing that threatens SECURACELL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.